<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Kamolwan Tantipiwatanaskul และผู้แต่งคนอื่นๆ. (2011) Influences of CYP2D6, CYP2C19 Polymorphisms on Fluoxetine pharmacokinetics and serotonin transporter Polymorphisms on clinical outcomes in Thai patients with depressive disorder. Chulalongkorn University:ม.ป.ท.</APA><Chicago>Kamolwan Tantipiwatanaskul และผู้แต่งคนอื่นๆ. 2011. Influences of CYP2D6, CYP2C19 Polymorphisms on Fluoxetine pharmacokinetics and serotonin transporter Polymorphisms on clinical outcomes in Thai patients with depressive disorder. ม.ป.ท.:Chulalongkorn University;</Chicago><MLA>Kamolwan Tantipiwatanaskul และผู้แต่งคนอื่นๆ.  Influences of CYP2D6, CYP2C19 Polymorphisms on Fluoxetine pharmacokinetics and serotonin transporter Polymorphisms on clinical outcomes in Thai patients with depressive disorder.  ม.ป.ท.:Chulalongkorn University, 2011. Print.</MLA></bibliography></xml>
